DataMeds AI, Inc. Amortization
DataMeds AI, Inc. (MEDS) reported Amortization of $657.92 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-08-17
- DataMeds AI, Inc. amortization for the quarter ending 2026-06-30 was $328.96K, a 56.89% decline year-over-year.
- DataMeds AI, Inc. amortization for the quarter ending 2026-03-31 was $328.96K, a 56.89% decline year-over-year.
- DataMeds AI, Inc. amortization for the quarter ending 2025-12-31 was $763.07K, a 25.75% increase year-over-year.
- DataMeds AI, Inc. amortization for the quarter ending 2025-09-30 was $763.07K, a 78.51% increase year-over-year.
- DataMeds AI, Inc. amortization for fiscal 2025 was $3.05M, a 191.51% increase from fiscal 2024.
- DataMeds AI, Inc. amortization for fiscal 2024 was $1.05M.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $328.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $657.92K 10-Q · filed 2026-08-17 | $1.42M derived: sum of 3 quarters · filed 2026-08-17 | $2.18M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $328.96K 10-Q · filed 2026-05-19 | $1.09M derived: sum of 2 quarters · filed 2026-05-19 | $1.86M derived: sum of 3 quarters · filed 2026-05-19 | $2.62M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $763.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.53M derived: sum of 2 quarters · filed 2026-03-20 | $2.29M derived: sum of 3 quarters · filed 2026-08-17 | $3.05M 10-K · filed 2026-03-20 |
| 2025-09-30 | $763.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.53M derived: sum of 2 quarters · filed 2026-08-17 | $2.29M 10-Q · filed 2025-11-19 | $2.90M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $763.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.53M 10-Q · filed 2026-08-17 | $2.13M derived: sum of 3 quarters · filed 2026-08-17 | $2.56M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $763.06K 10-Q · filed 2026-05-19 | $1.37M derived: sum of 2 quarters · filed 2026-05-19 | $1.80M derived: sum of 3 quarters · filed 2026-05-19 | |
| 2024-12-31 | $606.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.03M derived: sum of 2 quarters · filed 2026-03-20 | $1.05M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $427.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $440.25K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | $12.79K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |